Insmed vs STERIS

Insmed (INSM), health care, and STERIS (STE), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Insmed is worth $26.7B on the stock market and STERIS $25B: Insmed is valued at 7% more. Insmed's operating margin in its latest fiscal year was -206% and STERIS's 18.6%. Over the past year Insmed's share price has moved -39.1% and STERIS's +1.91%.

Key facts

Insmed market value
$26.7B
STERIS market value
$25B
STERIS P/E
30.5
Insmed revenue
$606.4MFY to 2025-12-31
STERIS revenue
$5.9BFY to 2026-03-31
Superinvestors holding both
0

Market values as of .

Insmed vs STERIS: every measure side by side
Measure Insmed STERIS
SectorHealth CareHealth Care
Country United States Ireland
Fiscal year ends2025-12-312026-03-31
Size
Market cap$26.7Bhigher$25Blower
Revenue$606.4Mlower$5.9Bhigher
Earnings-$1.3Blower$782.3Mhigher
Employees1,664lower17,937higher
Total assets$2.3Blower$10.7Bhigher
Valuation
P/E—30.5
P/S44.1higher4.2lower
P/B36.8—
Dividend yield0.00%—
Profitability
Operating margin-206%lower18.6%higher
Balance sheet
Net assets$739Mlower$7.2Bhigher
Total liabilities$1.5Blower$3.5Bhigher
Total debt$546.8Mlower$1.9Bhigher
Cash on hand$510.4Mhigher$439.6Mlower
Price change
Today-0.83%higher-1.46%lower
1 year-39.1%lower+1.91%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

STERIS only (1)

Percentages are each holding's share of that investor's reported portfolio. Who owns INSM · Who owns STE

Further comparisons

Learn

Questions and answers

Which is bigger, Insmed or STERIS?

By market value, Insmed is the larger: $26.7B against $25B for STERIS. By revenue in its latest fiscal year, STERIS is the larger: $5.9B against $606.4M for Insmed.

Which has the higher operating margin?

STERIS: 18.6%, against -206% for Insmed. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has more debt?

STERIS: $1.9B, against $546.8M for Insmed. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

Which superinvestors own both Insmed and STERIS?

None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Insmed and 1 holds STERIS.

Cite this page

Funkfolio, “Insmed vs STERIS”, data as of 17 November 2026. https://funkfolio.com/compare/insm-vs-ste

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.